aprotinin variants (Bayer)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameaprotinin variants (Bayer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin G inhibitorsTrypsin inhibitorsAlpha-2-antiplasmin modulators +[4] 
TargetsKallikreinsAlpha-2-antiplasminCathepsin G +[4] 
Therapy Area/IndicationsHeart FailureInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsHeart FailureInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A